Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Delta-9-tetrahydrocannabinol measurement (procedure) |
Has measured component (attribute) |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
|
Delta-9-tetrahydrocannabinol measurement (procedure) |
Component |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
1 |
Delta-9-tetrahydrocannabinol 27mg/mL/cannabinol 25mg/mL buccal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
|
Product containing cannabinol and delta-9-tetrahydrocannabinol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
2 |
Dronabinol (substance) |
Is a |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
|
Product containing only cannabinol and delta-9-tetrahydrocannabinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
2 |
Product containing cannabidiol and delta-9-tetrahydrocannabinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
2 |
Cannabidiol and delta-9-tetrahydrocannabinol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
2 |
Product containing cannabidiol and delta-9-tetrahydrocannabinol in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
2 |
Product containing only cannabidiol and delta-9-tetrahydrocannabinol in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Delta-9-tetrahydrocannabinol (substance) |
Inferred relationship |
Some |
2 |